Partager
Ecouter
  • Mergault C, Lisée F, Tiroille V, Magnien M, Parent C, Lenga Mabonda W, Sizaret D, Jaillet M, Crestani B, Marchand-Adam S, Plantier L. Inhibition of the Arp2/3 complex represses human lung myofibroblast differentiation and attenuates bleomycin-induced pulmonary fibrosis. Br J Pharmacol. 2022 Jan;179(1):125-140. doi: 10.1111/bph.15675. Epub 2021 Nov 15. PMID: 34453744.

  • Chesnay A, Paget C, Heuzé-Vourc'h N, Baranek T, Desoubeaux G. Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model. J Fungi (Basel). 2022 Jan 27;8(2):129. doi: 10.3390/jof8020129. PMID: 35205883; PMCID: PMC8877242.

  • Gangneux JP, Dannaoui E, Fekkar A, Luyt CE, Botterel F, De Prost N, Tadié JM, Reizine F, Houzé S, Timsit JF, Iriart X, Riu-Poulenc B, Sendid B, Nseir S, Persat F, Wallet F, Le Pape P, Canet E, Novara A, Manai M, Cateau E, Thille AW, Brun S, Cohen Y, Alanio A, Mégarbane B, Cornet M, Terzi N, Lamhaut L, Sabourin E, Desoubeaux G, Ehrmann S, Hennequin C, Voiriot G, Nevez G, Aubron C, Letscher-Bru V, Meziani F, Blaize M, Mayaux J, Monsel A, Boquel F, Robert-Gangneux F, Le Tulzo Y, Seguin P, Guegan H, Autier B, Lesouhaitier M, Pelletier R, Belaz S, Bonnal C, Berry A, Leroy J, François N, Richard JC, Paulus S, Argaud L, Dupont D, Menotti J, Morio F, Soulié M, Schwebel C, Garnaud C, Guitard J, Le Gal S, Quinio D, Morcet J, Laviolle B, Zahar JR, Bougnoux ME. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med. 2022 Feb;10(2):180-190. doi: 10.1016/S2213-2600(21)00442-2. Epub 2021 Nov 26. PMID: 34843666; PMCID: PMC8626095.

  • Sécher T, Bodier-Montagutelli E, Parent C, Bouvart L, Cortes M, Ferreira M, MacLoughlin R, Ilango G, Schmid O, Respaud R, Heuzé-Vourc'h N. Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological Effects. Pharmaceutics. 2022 Mar 18;14(3):671. doi: 10.3390/pharmaceutics14030671. PMID: 35336045; PMCID: PMC8949695.

  • Reidy L, Desoubeaux G, Cardenas J, Seither J, Kahl K, Chauvin D, Adkesson M, Govett P, Aitken-Palmer C, Stadler C, Tocidlowski M, Sirpenski G, Bronson E, Cray C. Detection of Gliotoxin but not bis(methyl)gliotoxin in plasma from birds with confirmed and probable aspergillosis. J Zoo Wild Med. 2022 Mar;53(1):60-69. doi: 10.1638/2021-0070. PMID: 35339150.

  • Al Ojaimi Y, Blin T, Lamamy J, Gracia M, Pitiot A, Denevault-Sabourin C, Joubert N, Pouget JP, Gouilleux-Gruart V, Heuzé-Vourc'h N, Lanznaster D, Poty S, Sécher T. Therapeutic antibodies - natural and pathological barriers and strategies to overcome them. Pharmacol Ther. 2022 May;233:108022. doi: 10.1016/j.pharmthera.2021.108022. Epub 2021 Oct 20. PMID: 34687769; PMCID: PMC8527648.

  • Thorel M, Mateos-Hernandez L, Mulot B, Azzouni MN, Hodžić A, Gaillot H, Ruel Y, Desoubeaux G, Delaye JB, Obregon D, Wu-Chuang A, de la Fuente J, Bermúdez-Humarán LG, Risco-Castillo V, Leclerc A, Cabezas-Cruz A. Assessment of the Safety and Efficacy of an Oral Probiotic-Based Vaccine Against Aspergillus Infection in Captive-Bred Humboldt Penguins (Spheniscus humboldti). Front Immunol. 2022 May 13;13:897223. doi: 10.3389/fimmu.2022.897223. PMID: 35634323; PMCID: PMC9137413.

  • Bretagne S, Sitbon K, Desnos-Ollivier M, Garcia-Hermoso D, Letscher-Bru V, Cassaing S, Millon L, Morio F, Gangneux JP, Hasseine L, Favennec L, Cateau E, Bailly E, Moniot M, Bonhomme J, Desbois-Nogard N, Chouaki T, Paugam A, Bouteille B, Pihet M, Dalle F, Eloy O, Sasso M, Demar M, Mariani-Kurkdjian P, Robert V, Lortholary O, Dromer F; French Mycoses Study Group. Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018). mBio. 2022 Jun 28;13(3):e0092022. doi: 10.1128/mbio.00920-22. Epub 2022 May 2. PMID: 35499498; PMCID: PMC9239099.

  • Desoubeaux G, Cray C, Chesnay A. Challenges to establish the diagnosis of aspergillosis in non-laboratory animals: looking for alternatives in veterinary medicine and demonstration of feasibility through two concrete examples in penguins and dolphins. Front Cell Infect Microbiol. 2022 Jul 19;12:757200. doi: 10.3389/fcimb.2022.757200. PMID: 35928207; PMCID: PMC9345302.

  • Cateau E, Leclerc A, Cartier N, Valsecchi I, Bailly É, Le Senechal R, Becerra M, Le Gallou B, Lavergne RA, Chesnay A, Robin JP, Cray C, Goddard N, Thorel M, Guillot J, Mulot B, Desoubeaux G. Aspergillosis in a colony of Humboldt penguins (Spheniscus humboldti) under managed care: a clinical and environmental investigation in a French zoological park. Med Mycol. 2022 Jul 9;60(7):myac046. doi: 10.1093/mmy/myac046. PMID: 35713494.

  • Pitiot A, Heuzé-Vourc'h N, Sécher T. Alternative Routes of Administration for Therapeutic Antibodies-State of the Art. Antibodies (Basel). 2022 Aug 26;11(3):56. doi: 10.3390/antib11030056. PMID: 36134952; PMCID: PMC9495858.

  • Reynard O, Gonzalez C, Dumont C, Iampietro M, Ferren M, Le Guellec S, Laurie L, Mathieu C, Carpentier G, Roseau G, Bovier FT, Zhu Y, Le Pennec D, Montharu J, Addetia A, Greninger AL, Alabi CA, Brisebard E, Moscona A, Vecellio L, Porotto M, Horvat B. Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection. Nat Commun. 2022 Oct 28;13(1):6439. doi: 10.1038/s41467-022-33832-6. PMID: 36307480; PMCID: PMC9616412.

  • Chesnay A, Bailly É, Cosson L, Flament T, Desoubeaux G. Advent of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis treatment: What consequences on Aspergillus-related diseases? Preliminary insights. J Cyst Fibros. 2022 Nov;21(6):1084-1085. doi: 10.1016/j.jcf.2022.09.007. Epub 2022 Sep 21. PMID: 36151024.

  • Mayor A, Thibert B, Huille S, Bensaid F, Respaud R, Audat H, Heuzé-Vourc'h N. Inhaled IgG1 antibodies: The buffering system is an important driver of stability during mesh-nebulization. Eur J Pharm Biopharm. 2022 Dec;181:173-182. doi: 10.1016/j.ejpb.2022.11.006. Epub 2022 Nov 14. PMID: 36395981.